Valuation Gedeon Richter LUXEMBOURG S.E.

Stocks

End-of-day quote LUXEMBOURG S.E. Other stock markets 2026-06-18			5-day change	1st Jan Change
38.40 ^USD	-2.04%		+1.05%	+27.15%

06-16	AI in Hungary could unlock productivity gains of EUR15 billion, McKinsey says	RE
06-10	Gedeon Richter Plc. and Hetero Labs Ltd. Announce Global Collaboration Agreement for Joint Development, Registration, and Commercialization of Semaglutide Injection	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	1,619,625	1,542,290	1,627,029	1,893,161	1,799,226	2,130,290	-	-
Change	-	-4.77%	5.49%	16.36%	-4.96%	18.4%	-	-
Enterprise Value (EV) ¹	1,559,769	1,395,557	1,546,536	1,782,343	1,588,618	1,815,700	1,708,900	1,590,286
Change	-	-10.53%	10.82%	15.25%	-10.87%	14.29%	-5.88%	-6.94%
P/E	11.6x	9.94x	10.2x	7.96x	7.76x	8.16x	7.48x	6.83x
PBR	1.78x	1.47x	1.44x	1.49x	1.31x	1.41x	1.28x	1.16x
PEG	-	0.9x	3.41x	0.2x	-2.82x	0.6x	0.83x	0.72x
Capitalization / Revenue	2.57x	1.92x	2.02x	2.21x	1.94x	2.24x	2.08x	1.94x
EV / Revenue	2.47x	1.74x	1.92x	2.08x	1.71x	1.91x	1.67x	1.45x
EV / EBITDA	8.86x	7.1x	6.43x	5.74x	4.5x	5x	4.38x	3.75x
EV / EBIT	11.5x	9.09x	8.15x	6.82x	5.42x	6.05x	5.23x	4.52x
EV / FCF	-460x	12.3x	17.9x	8.26x	7.56x	8.54x	7.39x	6.32x
FCF Yield	-0.22%	8.12%	5.6%	12.1%	13.2%	11.7%	13.5%	15.8%
Dividend per Share ²	225	390	-	-	-	620.6	664.4	733
Rate of return	2.58%	4.7%	-	-	-	5.31%	5.69%	6.28%
EPS ²	751	835	860	1,307	1,271	1,432	1,561	1,709
Distribution rate	30%	46.7%	-	-	-	43.3%	42.6%	42.9%
Net sales ¹	630,595	802,755	805,158	857,545	928,962	951,724	1,023,546	1,098,192
EBITDA ¹	176,123	196,480	240,625	310,678	353,314	363,366	389,794	424,113
EBIT ¹	135,832	153,555	189,817	261,157	292,851	299,996	326,732	351,898
Net income ¹	139,626	155,581	158,850	239,244	232,335	259,474	286,154	313,070
Net Debt ¹	-59,856	-146,733	-80,493	-110,818	-210,608	-314,590	-421,390	-540,005
Reference price ²	8,725.00	8,300.00	8,750.00	10,400.00	9,865.00	11,680.00	11,680.00	11,680.00
Nbr of stocks (in thousands)	185,630	185,818	185,946	182,035	182,385	182,388	-	-
Announcement Date	3/2/22	2/28/23	2/29/24	4/7/25	2/27/26	-	-	-

¹HUF in Million²HUF

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	37.64x	7.13x	24.31x	0.82%	46.46B
OTSUKA HOLDINGS CO., LTD.	18x	2.02x	9.57x	1.34%	35.42B
CIPLA LIMITED	26.16x	3.21x	16.43x	0.92%	11.62B
ZYDUS LIFESCIENCES LIMITED	23.56x	4.11x	15.32x	0.75%	11.47B
KRKA, D. D.	19.71x	3.4x	12.36x	3.46%	9.13B
ONO PHARMACEUTICAL CO., LTD.	15.01x	1.97x	7.47x	3.57%	6.65B
GLENMARK PHARMACEUTICALS LIMITED	32.7x	3.71x	15.8x	0.24%	6.45B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	40.51x	-	-	-	5.01B
Average	26.66x	3.65x	14.47x	1.59%	16.53B
Weighted average by Cap.	27.64x	4.37x	16.50x	1.27%